2017
Galectin‐9 is a Novel Modulator of Epithelial Restitution

Brian Scott Robinson , Bejan Saeedi , Crystal Naudin , Connie Arthur
The FASEB Journal 32 414.1 -414.1

1
2018
The tethered spinal cord. Etiology and clinical manifestations.

Schmidt Dm , Jones Da , Robinson B
Orthopaedic review 19 ( 10) 870

12
1990
The Ecdysone Receptor Coactivator Taiman Links Yorkie to Transcriptional Control of Germline Stem Cell Factors in Somatic Tissue

Can Zhang , Brian S. Robinson , Wenjian Xu , Liu Yang
Developmental Cell 34 ( 2) 168 -180

44
2015
Cell–Cell Junctions: α-Catenin and E-Cadherin Help Fence In Yap1

Brian S. Robinson , Kenneth H. Moberg
Current Biology 21 ( 21)

20
2011
144 NRF2 REGULATES A NOVEL PROLIFERATIVE CHECKPOINT IN INTESTINAL EPITHELIA

Brian Robinson , Bejan Saeedi , Josh Owens , Crystal Naudin
Gastroenterology 158 ( 6)

2020
Regulation of oxidative liver injury by the probiotic Lactobacillus rhamnosus GG

Bejan Jon Saeedi , Brian Robinson , Joshua Owens , Ken Liu
The FASEB Journal 32 150 -4

1
2018
Analysis of KRAS mutations in gastrointestinal tract adenocarcinomas reveals site-specific mutational signatures

Linyuan Wang , Bejan J Saeedi , Zaid Mahdi , Alyssa Krasinskas
Modern Pathology 36 ( 2) 100014 -100014

3
2023
The human commensal lactobacillus rhamnosus GG orchestrates an anti-tumor immune response

Josh Owens , Bejan Saeedi , Crystal Naudin , Sarah Hunter-Chang
Cancer Research 80 ( 16_Supplement) 3344 -3344

2020
A discovery platform to identify novel beneficial bacteria

Trevor Darby , Joshua Owens , Bejan Saeedi , Liping Luo
The FASEB Journal 32 406.11 -406.11

2018
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell–and CXCR3-dependent manner

Michael Brandon Ware , Maggie Phillips , Christopher McQuinn , Mohammad Y Zaidi
JCI insight 8 ( 8)

8
2023
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma

Sruthi Ravindranathan , Tenzin Passang , Jian-Ming Li , Shuhua Wang
Nature Communications 13 ( 1) 6418 -6418

12
2022
Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer

Emilie AK Warren , Jacklyn N Hammons , Jessica M Keilson , Guillermo O Rangel Rivera
ANNALS OF SURGICAL ONCOLOGY 31 ( 1) S28 -S28

2024
Galectin-9 as a regulator of immune interactions in the tumor microenvironment and novel therapeutic target in biliary tract cancer.

Emilie AK Warren , Jacklyn Hammons , Jessica M Keilson , Megan Wyatt
Journal of Clinical Oncology 42 ( 3_suppl) 555 -555

2024
1507 The Galectin-9-Tim-3 pathway is a novel checkpoint target for patients with biliary tract cancer

Emilie AK Warren , Jacklyn Hammons , Jessica Keilson , Guillermo O Rangel-Rivera
Journal for ImmunoTherapy of Cancer 11 ( Suppl 1)

2023
Galectin-9 expression and decreased survival in advanced biliary tract cancers.

Jessica M Keilson , Amanda Ruggieri , Jacklyn Hammons , Helen X Chen
Journal of Clinical Oncology 40 ( 4_suppl) 465 -465

2022